Close
Protect your central vision with specialized care for dry and wet AMD at NERSI Eye Care. Our board-certified specialist uses advanced retinal diagnostics and personalized treatment plans to slow progression and preserve your long-term eyesight before irreversible damage occurs.
Macular degeneration is an age-related eye condition that affects the macula, the part of the retina responsible for central vision, making tasks like reading and recognizing faces progressively more difficult.
Unlike peripheral vision, which allows you to see to the sides, central vision is what you rely on for sharp, detailed sight directly in front of you. The macula is the small but critical area of the retina that makes this possible. When it begins to deteriorate, the clarity of everything you look at directly starts to decline, often gradually at first, then more noticeably as the condition advances.
The earlier a patient seeks Macular Degeneration Treatment in Ashburn, VA, the better the outcome. Many patients lose meaningful vision before being evaluated simply because the early stages do not always produce obvious symptoms. At NERSI, early detection screening is a core part of our AMD treatment approach, because identifying the condition before it progresses changes outcomes in ways that later intervention cannot replicate.
Whether you have recently been diagnosed or are noticing early changes in your central vision, speaking with a retina specialist in Ashburn promptly is the most important step you can take right now.
Direct Answer Box: Macular degeneration affects the macula, the retinal region responsible for sharp central vision. It progresses gradually in its dry form and more rapidly in its wet form, making early diagnosis and treatment essential to preserving usable sight.
Understanding which type of macular degeneration you have is the foundation of effective treatment. The two forms differ significantly in their cause, pace of progression, and management approach.
Dry AMD is the most common form, accounting for the majority of macular degeneration diagnoses. It occurs when the macula gradually thins over time due to the accumulation of small deposits called drusen beneath the retina. Vision loss is slower and more gradual with dry AMD, though it can advance to the late stage known as geographic atrophy, where significant retinal tissue is lost. There is currently no cure for dry AMD, but progression can be monitored and meaningfully slowed with consistent management.
Wet AMD is less common but far more aggressive. It occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood into the macula, causing rapid and often severe central vision loss. Because vision can deteriorate significantly within weeks, this form requires timely medical intervention.
Quick Comparison: Dry AMD progresses slowly over years and is managed through monitoring and lifestyle strategies. Wet AMD progresses rapidly and requires active medical treatment, typically Anti-VEGF injections, to stop the leaking blood vessels driving the damage.
What are the early signs of macular degeneration? Recognizing these symptoms early and acting on them quickly is what makes age-related macular degeneration treatment in Ashburn most effective at preserving vision.
A gradual or sudden blurring in the center of your visual field is one of the most consistent early signs of macular disease. Unlike blurriness caused by a refractive error, this type does not improve with a new glasses prescription.
Because the macula governs fine detail, reading printed text, following lines on a screen, and recognizing the features of a face at close or moderate range all become progressively harder as the macula deteriorates.
Patients with advancing macular degeneration often describe a dark patch, shadow, or blank area in the center of their vision. This represents areas of the macula where retinal cells have been damaged or lost.
Straight lines that appear distorted or curved, such as the edges of a door frame or text lines on a page, are a hallmark symptom of wet AMD and should prompt immediate evaluation. This is commonly tested using an Amsler grid during a retinal examination.
Macular degeneration is primarily driven by age-related changes to the retinal cells and supporting tissue of the macula. These changes accumulate over decades and are shaped by a combination of biological predisposition and lifestyle factors.
Age is the single most significant risk factor. The likelihood of developing AMD rises substantially after 50 and increases sharply with each passing decade. Retinal cells in the macula become less efficient at clearing waste products over time, leading to the deposits and structural changes that define the condition.
AMD has a strong hereditary component. Patients with a first-degree relative who has been diagnosed carry a significantly elevated lifetime risk and benefit from earlier and more frequent screening than the general population.
Smoking is the most significant modifiable risk factor for macular degeneration. It accelerates oxidative damage to retinal tissue and is associated with considerably faster disease progression in both dry and wet forms of AMD.
Elevated blood pressure reduces the quality of blood flow to the retina and increases the risk of developing and advancing AMD. Addressing systemic health is a meaningful component of long-term dry macular degeneration management in Ashburn and beyond.
A diet low in antioxidants and leafy green vegetables, prolonged ultraviolet light exposure without eye protection, and obesity have all been linked to elevated AMD risk in clinical research.
A confirmed macular degeneration diagnosis requires more than a standard vision check. At NERSI, the evaluation follows a structured sequence of assessments designed to detect the condition at its earliest stage and distinguish between dry and wet forms before any treatment decisions are made.
Treatment depends on the type and stage of macular degeneration, with the primary goal being to slow progression and preserve as much functional vision as possible. At NERSI, Macular Degeneration Treatment in Ashburn, VA is built around each patient’s specific diagnosis rather than applied as a fixed protocol.
Wet AMD requires active medical intervention to stop the abnormal blood vessel growth driving rapid vision loss.
There is currently no medication that reverses dry AMD, but progression can be meaningfully slowed through consistent monitoring and evidence-based management.
Every patient at NERSI receives a care plan built around their specific stage, type, and risk profile rather than a one-size-fits-all pathway.
Patients who benefit most from Macular Degeneration Treatment in Ashburn, VA share certain characteristics. You may be a candidate for evaluation and ongoing care if you fall into one of the following categories.
Age is the primary driver of AMD risk. Routine retinal screening beginning at 50, or earlier with additional risk factors present, allows for detection before symptoms surface and before vision is already compromised.
If a parent or sibling has been diagnosed with macular degeneration, your lifetime risk is meaningfully elevated. Earlier and more frequent screening is recommended for anyone with this hereditary predisposition.
Any new blurring, distortion, or blank spots in central vision warrants prompt evaluation. Even subtle changes in how clearly you can read print or how straight lines appear are worth investigating with a retina specialist in Ashburn before they progress.
For patients who have received a diagnosis elsewhere and are looking for ongoing care, NERSI offers comprehensive AMD treatment in Ashburn and structured monitoring using advanced retinal imaging to track the condition accurately over time.
See an eye doctor immediately if you notice changes in your central vision, distortion in straight lines, or increasing difficulty reading. Starting wet macular degeneration treatment in Ashburn early can slow or halt progression before significant vision is permanently lost.
Do not wait for symptoms to worsen before seeking an evaluation. Book an appointment if:
Same-day emergency appointments are available at NERSI for patients experiencing sudden or rapid changes in vision.
NERSI's diagnostic suite includes OCT, fundus photography, and visual field testing, giving Dr. Bajwa the imaging data needed to catch AMD at its earliest stage and monitor changes with precision at every follow-up visit.
Dr. Bajwa's subspecialty training at Yale University and her clinical study under Dr. Foster at MERSI in Boston give her a depth of retinal disease experience that goes well beyond general ophthalmology practice.
No two AMD cases are identical. Your care plan at NERSI reflects your specific type, stage, risk factors, and goals, and is adjusted as your condition and response to treatment evolve over time.
Our approach to Macular Degeneration Treatment in Ashburn, VA is built around an ongoing relationship with your eye health, not a single appointment. Structured monitoring is part of your care from day one.
Located at 44095 Pipeline Plaza, Suite 330, off Loudoun County Parkway near Route 28. Easily accessible from One Loudoun, Brambleton, Broadlands, Sterling, Leesburg, Herndon, Chantilly, and Reston.
Dr. Bajwa brings subspecialty precision to every patient she sees for age-related macular degeneration treatment in Ashburn. Her fellowship training at Yale University and advanced clinical study under Dr. Foster at MERSI in Boston gave her a retinal disease foundation that goes well beyond the scope of routine eye care.
For AMD patients at NERSI, that means a physician who combines advanced imaging with individualized clinical judgment at every visit, evaluating and treating each patient directly rather than delegating across layers of technicians.
Credentials:
Dr. Asima Bajwa, MD | Board-Certified Ophthalmologist
Yes, though the approach depends on the type. Wet AMD is treated with Anti-VEGF injections to stop abnormal blood vessel growth and stabilize vision. Dry AMD is managed through monitoring, nutritional guidance, and lifestyle strategies to slow progression.
In many wet AMD patients, yes. Injections can stabilize vision and in some cases produce measurable improvement in clarity, particularly when treatment begins before significant retinal damage has occurred.
See a doctor immediately if you notice any change in central vision, distortion of straight lines, or dark spots in your visual field. Early evaluation is the single most important factor in protecting your remaining sight.
Blurring or distortion in the center of your vision, straight lines appearing wavy, or difficulty reading despite a current glasses prescription are all signs that a macular degeneration diagnosis evaluation is worth pursuing promptly.
Only if you have wet AMD. Anti-VEGF injections are the primary treatment for wet AMD, targeting the abnormal blood vessel growth that causes rapid vision deterioration. Dry AMD does not currently require injections.
Visit frequency depends on your type and stage. Wet AMD patients receiving injections are typically seen monthly or every two to three months. Dry AMD patients are monitored on a schedule determined by the rate of progression seen through imaging.
Your exam includes a vision assessment, Amsler grid testing, comprehensive retinal imaging with OCT and fundus photography, and a direct clinical evaluation by Dr. Bajwa to determine AMD type, stage, and next steps.
As soon as you notice them. Central vision changes are not a normal part of aging and should always be evaluated without delay. Waiting reduces the effectiveness of available AMD treatment options considerably.
Early detection gives you the best chance of preserving your vision. Schedule a consultation at NERSI for a thorough retinal evaluation and a care plan built specifically around your condition and stage.
Same-day emergency appointments available. Monday through Friday, 7:30 AM to 4:00 PM. Located at 44095 Pipeline Plaza, Suite 330, Ashburn, VA 20147.
Please note: To help us stay on schedule and accommodate all patients, new patients who arrive 15 minutes or more after their scheduled appointment may need to be rescheduled. If you are running late, please call our clinic to let us know. Thank you.
Copyright © 2026 Nur Eye Research and Surgery Institute. All rights reserved.
Designed and Marketing By Verbsz Marketing
